Coronavirus fatalities ebb in Jharkhand, 831 fresh cases reported

Jharkhand reported 14 new COVID-19 deaths on Tuesday, continuing with the declining trend of fatalities, even as 831 more people tested positive, a health department bulletin said

virus, labs, coronavirus, bio weapons, research, biological warfare
Press Trust of India Ranchi
2 min read Last Updated : Jun 01 2021 | 9:01 PM IST

Jharkhand reported 14 new COVID-19 deaths on Tuesday, continuing with the declining trend of fatalities, even as 831 more people tested positive, a health department bulletin said.

The death toll rose to 4,991, while the coronavirus tally stood at 3,37,774, it said.

The state had reported 19 deaths on Monday and 13 fatalities the day before, the lowest in a single day last month.

No one succumbed to the virus since Monday in 19 of the 24 districts of the state, including Bokaro, Deoghar, Dhanbad, Dumka, Giridih, Hazaribag and West Singhbum, the bulletin said.

Jharkhand now has 8,907 active cases, while 3,23,876 patients have recovered from the disease.

Altogether, 84,84,836 samples have been tested for COVID-19 in Jharkhand, including 50,338 since Monday, it added.

The state has sought the Centre's intervention, including free vaccines, to tide over the crisis and has also ordered a death audit in five districts witnessing high fatalities.

Chief Minister Hemant Soren in a letter to Prime Minister Narendra Modi termed the mandate for states to procure medicines as against cooperative federalism.

"This is probably for the first instance in the history of independent India that the states have been mandated to procure vaccines on their own," he said.

Since the advent of the second wave of COVID-19, the death rate in the state increased from 0.9 per cent to 1.46 per cent, as several districts reported high number of fatalities.

In a bid to curb the spread of the virus, the state government has extended the lockdown till June 3.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusJharkhandCoronavirus Vaccine

First Published: Jun 01 2021 | 9:00 PM IST

Next Story